JTCS KCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ricco, J.-B.
Right arrow Articles by Corsini, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ricco, J.-B.
Right arrow Articles by Corsini, A.
Related Collections
Right arrow Great vessels
Right arrowRelated Article

J Thorac Cardiovasc Surg 2006;131:131-137
© 2006 The American Association for Thoracic Surgery

Evolving Technology

Stent-graft repair for thoracic aortic disease: Results of an independent nationwide study in France from 1999 to 2001

Jean-Baptiste Ricco, MD, PhD a , * , Jérome Cau, MD a , Christophe Marchand, MD a , Michel Marty, MD b , Marie-Hélène Rodde-Dunet, MD b , Pierre Fender, MD b , Hubert Allemand, MD b , Andrew Corsini, BA a

a Vascular Surgery Department, University Hospital, Poitiers, France
b French National Health Insurance Fund for Salaried Workers, French Ministry of Health, Paris, France

Received for publication February 9, 2005; revisions received July 11, 2005; accepted for publication July 19, 2005.

* Address for reprints: Jean-Baptiste Ricco, MD, PhD, Department of Vascular Surgery, University Hospital of Poitiers, rue de la Miletrie, 86000 Poitiers, France (Email: j.b.ricco{at}chu-poitiers.fr).


   Abstract
Top
 Abstract
Introduction
 Patients and Methods
 Results
 Discussion
 References
 
BACKGROUND: The purpose of this study was to assess the overall short-term outcome of stent-graft repair for thoracic aortic disease in France between June 1999 and May 2001.

METHODS: This retrospective study was designed by the French National Health Insurance Fund for Salaried Workers. To ensure objectivity, data were retrieved at each center and checked by a team of medical advisors.

RESULTS: Between June 1999 and May 2001, a total of 166 stent-graft repairs for thoracic aortic disease were performed in 166 patients, mainly by surgeons in the operating room (88%). Patients were classified according to the American Society of Anesthesiologists as status I or II in 24% of cases, status III in 56%, and status IV or V in 20%. The diameter of the thoracic aneurysm was less than 50 mm in 17% of cases. Seventeen patients (10%) died during the first 3 months, including 8 within the first 30 days after the procedure. A total of 49 complications were noted in 34 patients (20.5%). Endoleaks occurred in 27 patients (16.3%), including 8 that necessitated further treatment. Other stent-related complications included rupture (n = 3), aortoesophageal or tracheal fistula (n = 3), paraplegia (n = 6), stent migration (n = 2), visceral embolism (n = 5), and cerebral embolism (n = 2). There were 14 delivery-related complications (8%) at the catheterization site. Non–stent-related complications occurred in 14 (8%).

CONCLUSIONS: This nationwide study demonstrates that stent-graft repair for thoracic aortic disease can be performed with acceptable postoperative morbidity. However, it is not a risk-free procedure and should continue to be used in an investigative setting.

Abbreviations and Acronyms ASA = American Society of Anesthesiologists; CI = 95% confidence interval; TAD = thoracic aortic disease


   Introduction
Top
 Abstract
 Introduction
Patients and Methods
 Results
 Discussion
 References
 

Figure 1
Dr Ricco


GoEndovascular repair is a potentially beneficial alternative to conventional open surgery for the entire spectrum of thoracic aortic disease (TAD). Even when performed at specialized centers, conventional open repair is associated with significant morbidity, including paraplegia, and 30-day mortality rates from 5% to 20% in degenerative aneurysm and 6% to 67% in type B aortic dissection. 1-8 Go

Use of endovascular techniques has progressed more slowly for TAD than for infrarenal aortic aneurysm. However, the use of endovascular stent-graft procedures for TAD has increased since the first procedures were reported first by Volodos and colleagues 9 Go in 1991 and then by Dake and colleagues 10 Go in 1994.

In June 2000, the French Agency for Sanitary Safety of Healthcare Products, in compliance with European Directive 93/42 EEC of June 1993, conducted a thorough study to evaluate the safety of aortic stent grafts. 11 Go In 2002, the French National Health Insurance Fund for Salaried Workers undertook an exhaustive nationwide survey to evaluate postoperative complications after placement of stent grafts for abdominal aortic aneurysm and TAD. The results of the survey concerning abdominal aortic aneurysm were published in 2003. 12 Go The purpose of this article is to describe the findings concerning the overall short-term outcome of stent-graft repair for TAD in France between June 1999 and May 2001.


   Patients and Methods
Top
 Abstract
 Introduction
 Patients and Methods
Results
 Discussion
 References
 
Study Design
This study was designed to allow analysis independent of administrative or commercial interests. It was conducted by a team of medical advisors from the French National Health Insurance Fund for Salaried Workers. Medical advisors are physicians responsible for overseeing reimbursements. No medical advisor investigated an institution where he or she had formerly practiced.

Data Collection
Data were collected from the medical charts of all patients who underwent stent-graft repair for TAD in France from June 1, 1999, to May 31, 2001. Patients were identified by using the list of all centers performing vascular surgery, interventional radiology, or cardiology in France. In addition, the computerized PMSI (Le Programme de Médicalisation du Système d'Information) coding system (diagnosis-related groups) was searched to identify institutions caring for patients with TAD. The key words for the search included aortic aneurysm as the principal diagnosis in association with 10 International Classification of Diseases codes (171.0 to 171.9) and the so-called surgical homogenous patient groups in the diagnosis category 05 (homogenous patient groups 158, 159, 160, 168, and 172). To further ensure that no procedure was overlooked, medical advisors met with representatives of medical device vigilance departments to obtain a list of all reported devices and accidents and consulted compulsory registers for procedures performed in operating rooms and radiology suites.

Scope of Data
All data concerning procedures involving insertion or ablation of a stent graft for TAD were recorded, including clinical setting, patient characteristics, TAD features, clinical findings, and postoperative outcome. For adverse outcomes, a distinction was made between stent- or procedure-related events and non–stent-related complications.

Statistical Analysis
Statistical analysis was performed with GraphPad software (GraphPad, San Diego, Calif). Variables were cross-checked, and queries concerning missing or aberrant data were sent to regional project directors. Percentages were calculated with 95% confidence interval (CI). Life-table analysis was performed by using the Kaplan-Meier method with 95% confidence interval.


   Results
Top
 Abstract
 Introduction
 Patients and Methods
 Results
Discussion
 References
 
During the 2-year study period, 166 endovascular stent-graft repairs for TAD were performed in 29 centers. The number of stent grafts inserted per center was 1 at 8 centers, 2 to 5 at 17 centers, and 6 to 15 at 4 centers.

Patient Characteristics
Most patients, ie, 86% (n = 142), were men. The mean age was 69 ± 15 years (range, 20-91 years). American Society of Anesthesiologists (ASA) scores were determined on the basis of associated risk factors in 129 patients (78%). There were 31 patients (24%) with ASA status I or II, 72 (56%) with ASA status III, and 26 (20%) with ASA status IV. The overall median duration of hospitalization was 10 days (range, 5-64 days). As shown in Table 1, the most common type of TAD was asymptomatic degenerative aneurysm, in 53% of cases (n = 90). Patients with chronic dissecting aneurysm (n = 33) presented no complications before stent-graft insertion, but 4 had thoracic pain without hemothorax.


View this table:
[in this window]
[in a new window]
  		TABLE 1. Etiology of thoracic aortic disease treated with stent grafts in France from June 1, 1999, to May 31, 2001
 
Preoperative Workup
All 166 patients underwent preoperative imaging with spiral computed tomographic scan. In addition, digitized angiography with placement of a graduated catheter in the thoracic aorta was performed in 127 cases (77%). All lesions were located in the descending thoracic aorta. As shown in Table 2, the maximum aneurysm diameter, excluding patients with trauma (n = 17) and aortic ulceration (n = 23), was less than 50 mm in 21 patients (17%).


View this table:
[in this window]
[in a new window]
  		TABLE 2. Maximum diameter of 126 thoracic aortic aneurysms * treated with stent grafts in France from June 1, 1999, to May 31, 2001
 
Stent Grafts and Implantation Procedures
As shown in Table 3, 6 different stent-graft models were used. All commercially available devices used in this study had received the CE mark. Implantation was performed in an operating room equipped with a C-arm in 147 cases (88%) and in a radiology suite in 19 cases (12%). The procedure involved first-time stenting in 160 cases (96%) and repeat stenting in 6 cases (3.6%). As shown in Table 4, stent-graft repair was associated with other procedures in 39 patients (23.5%). Concomitant transposition of the left subclavian artery was required in 15 patients (9%) who had aneurysms with short necks arising near the origin of the subclavian artery. Concomitant aortic or iliac bypass was needed to allow implantation of the stent graft in 9 patients (5.5%). Concomitant infrarenal abdominal aortic aneurysm repair was performed in 8 patients (5%).


View this table:
[in this window]
[in a new window]
  		TABLE 3. Type of aortic stent grafts used in patients undergoing endovascular repair for thoracic aortic disease in France from June 1, 1999, to May 31, 2001
 

View this table:
[in this window]
[in a new window]
  		TABLE 4. Concomitant procedures (n = 39) in patients undergoing stent-graft repair for thoracic aortic disease in France from June 1, 1999, to May 31, 2001
 
Immediate Complications
Thirty-day follow-up data were available for 163 patients (98%; CI, 95%-99%), including angiography, computed tomography with helical 3-dimensional reconstructions, and plain chest radiography. In the first 30 days, there were 8 deaths. Nine additional deaths related to immediate postoperative complications occurred during hospitalization beyond the first 30 days. In all, 17 patients (10%; CI, 6%-16%) died in the hospital. Tables 5 and 6 Go show analysis of mortality as a function of etiology and ASA score, respectively. Table 7 shows analysis of mortality and procedure- or stent-related morbidity, including type I endoleaks, as a function of the extent of aorta covered by the stent graft. Table 8 shows mortality and morbidity as a function of the diameter of the thoracic aneurysm. The percentage of complications with each of the stent-graft models was comparable (P = .04). Survival based on life-table analysis was 86% ± 6% at 6 months (Figure 1).


View this table:
[in this window]
[in a new window]
  		TABLE 5. Postoperative mortality as a function of etiology in patients undergoing stent-graft repair for thoracic aortic disease in France from June 1, 1999, to May 31, 2001
 

View this table:
[in this window]
[in a new window]
  		TABLE 6. Mortality and morbidity, excluding endoleaks, as a function of the ASA score in patients undergoing stent-graft repair for thoracic aortic disease
 

View this table:
[in this window]
[in a new window]
  		TABLE 7. Mortality and procedure- or stent-related morbidity, including type I and III endoleaks, as a function of the extent of aorta covered by the stent graft in patients undergoing endovascular repair for thoracic aortic disease
 

View this table:
[in this window]
[in a new window]
  		TABLE 8. Mortality and morbidity as a function of the diameter of 126 thoracic aortic aneurysms treated with stent grafts in France from June 1, 1999, to May 31, 2001
 

Figure 1
View larger version (14K):
[in this window]
[in a new window]
  		Figure 1. Kaplan-Meier curve depicting the cumulative survival of the patient cohort with 95% confidence intervals (dotted lines) and patients at risk for each interval. Survival at 6 months was 86% ± 6%.

 
Table 9 summarizes the failures and complications observed. Endoleak occurred in 27 cases (16.3%; 95 CI, 11%-22%), including 6 type I endoleaks that necessitated further treatment: conversion to open repair in 1 case and repeat stent grafting in 5 cases. These type I endoleaks were related to suboptimal proximal landing zones of 10 to 15 mm in length with an angulation of 60° or more from the transverse arch. In addition, 3 type III endoleaks occurred between 2 stent grafts with an angulation of 60° to 80° in the descending thoracic aorta. Finally, 18 type II endoleaks were diagnosed on postoperative computed tomographic scans performed within the first postoperative month and were left untreated. In addition to endoleaks, there were 49 complications (29%; CI, 23%-37%) in 34 patients (20%; CI, 15%-27%). Thirty-five complications were related to the stent graft or procedure, and 14 were not stent related. The stent- or procedure-related complications were rupture in 3 cases, aortoesophageal or tracheal fistula resulting from stent-graft insertion in 3, paraplegia in 6, visceral embolism in 5, stent migration with visceral ischemia in 2, cerebral embolism in 2, and catheterization-site complications in 14, including iliac artery perforation in 5 cases and iliac thrombosis or peripheral embolism in 9 cases. All 6 cases of paraplegia (3.6%; CI, 1.5%-7.9%), including 5 that were fatal, occurred within 48 hours after the procedure. Three cases occurred in patients with extensive degenerative aneurysm of the descending aorta with concomitant open repair of an infrarenal aortic aneurysm. Three other cases occurred in patients with type B dissecting aneurysms with a stent graft covering proximal entry tears in the descending thoracic aorta. Paraplegia was also associated with other major complications in 5 patients (Table 9). Spinal drainage was not used in these patients because in 1999 to 2001, there was no evidence that cerebrospinal fluid drainage was necessary in these patients. 10,13 Go Although no definitive statement about the comparative risks of spinal cord ischemia with open repair is possible, this study suggests that even if the risk of spinal cord ischemia with thoracic stent graft is low, these patients should have cerebrospinal fluid drainage and prevention of hypotension, as used in open repair. In this series, actuarial freedom from endoleak and other complications at 6 months was 63% ± 7% (Figure 2).


View this table:
[in this window]
[in a new window]
  		TABLE 9. Complications and treatment failures during the postoperative period
 

Figure 2
View larger version (15K):
[in this window]
[in a new window]
  		Figure 2. Kaplan-Meier curve depicting freedom from failure and complications, ie, rupture, endoleak, migration, embolism, conversion, and non–stent-related complications, with 95% confidence intervals (dotted lines) and patients at risk for each interval. The cumulative freedom from failure and complications at 6 months was 63% ± 7%.

 

   Discussion
Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Discussion
References
 
This exhaustive study of 166 patients undergoing stent-graft repair of TAD provides useful insights into the short-term postoperative outcome. Like previous studies, 13-17 Go our findings demonstrated that stent-graft repair could provide a less invasive alternative to conventional open repair. However, it must be emphasized that follow-up was limited to the postoperative period.

Only 4 (2.4%) of the 17 deaths in this series were in direct relation to preoperative patient status. This relatively low general mortality is especially remarkable insofar as 76% of patients were classified as ASA status III to IV. Indeed, all 17 deaths (10%) occurred in patients classified as ASA status III to IV. Only 8 deaths (4.8%) occurred within the first 30 days, but 9 other patients died as a consequence of postoperative complications beyond 30 days.

Thirty-five complications were related to the stent graft or procedure, including 3 ruptures in relation to endoleak, 3 aortoesophageal or tracheal fistulas, and 7 cases of postoperative visceral ischemia. Intraoperative stent-graft migration was observed during deployment in 2 patients with suboptimal proximal landing zones, and this necessitated transposition of the left subclavian artery. These 2 complications provide further evidence of the importance of careful assessment of anatomic features for patient selection.

In addition to the 3 patients who had fatal endoleak-related rupture, endoleaks were observed in 24 patients. Type I endoleaks occurred at the proximal landing zone in patients with a large proximal neck diameter or sharp angulation of the thoracic aorta. A predisposing factor for type I endoleak was separation and dislocation of modular devices with sharp angulation of the descending thoracic aorta. The incidence of endoleaks in this series (16.3%) is in agreement with previous reports 17 Go and emphasizes the importance of patient selection and the need for improving stent-graft design, especially with regard to column strength and attachment. 18,19 Go

This high rate of stent-related complications is currently a major limitation for using endovascular repair in low-operative-risk patients, in whom conventional open repair usually achieves durable results with a negligible risk of graft complications or aortic rupture. 20,21 Go However, this disadvantage may be offset by the lower postoperative mortality and morbidity of stent-graft repair in comparison with open surgery.

Paraplegia was observed in only 6 patients (3.6%) in this study. This rate is similar to that reported by Mitchell and associates 16 Go in a comparable series. All 6 patients in whom paraplegia developed in our series had a large aneurysm of the descending aorta. In 3 cases, stent-graft repair was associated with concomitant abdominal aortic aneurysm repair, which was cited as a risk factor for paraplegia in the Stanford experience. 22 Go

Our data indicate that stent-graft repair for type B aortic dissection has yet to overcome limitations associated with multiple re-entry tears and flow to aortic branches provided by the false lumen. 23 Go Mortality after stent-graft repair for type B aortic dissection was 15.2% in our series, similar to the results described by Dake and associates. 22 Go These findings contradict previous suggestions that stent-graft repair for type B dissection has the potential advantages of containing rupture, obliterating the false lumen, and protecting against the long-term risk of aneurysm. 22 Go

Our study suggests that stent-graft repair is a valuable alternative to emergency surgical replacement for traumatic pseudoaneurysm. In this subgroup, only 1 patient (5.8%) died, and none had paraplegia. These rates contrast with those reported in contemporary series 24 Go using emergency surgical repair for aortic trauma.

This study shows that stent-graft repair for septic aneurysm is particularly challenging. Two of the 3 patients treated for septic aneurysm died during the postoperative period. Despite the publication by Semba and colleagues 25 Go of 2 cases of septic thoracic aneurysm successfully treated by stent graft, this concept is not substantiated by evidence even as a bridge to open repair with a homograft.

A disappointing finding of our study was the failure of some surgeons to apply the basic consensus guidelines, which recommend surveillance rather than treatment for thoracic aneurysms smaller than 50 mm. 5 Go Seventeen percent of the stent-graft procedures, excluding patients with aortic ulcer and trauma, involved patients with aneurysms smaller than 50 mm in diameter. Several explanations can be proposed, including overenthusiasm for the short-term benefits of a new "less-invasive" technology. However, it should be noted that, as shown in Table 8, mortality from thoracic aortic aneurysms smaller than 50 mm in diameter (4.7%) was not significantly different (P = .69) from that of thoracic aortic aneurysms 50 mm or larger (11.4%).

Several factors may restrict the value of this study, including its retrospective nature, the absence of a matched surgical group, short-term follow-up, and use of first- or second-generation stent grafts. These weaknesses are balanced by the fact that data including complications were thoroughly collected and cross-checked. Despite these limitations, it should be said that our data mirror the experience of other investigators 10,13,22 Go and are comparable to those of other investigators who used last-generation stent grafts. 14,15,24 Go This nationwide study demonstrates that stent-graft repair for TAD can be performed with acceptable postoperative morbidity.


See related editorial on page 16.

 


   References
Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Discussion
 References
 

  1. Ellozy SH, Carroccio A, Minor M, Jacobs T, Chae K, Cha A, et al. Challenges of endovascular tube graft repair of thoracic aortic aneurysm. midterm follow-up and lessons learned. J Vasc Surg 2003;38:676-683.[Medline]
  2. Cambria RP, Davison JK, Carter C, Brewster DC, Chang Y, Clark KA, et al. Epidural cooling for spinal cord protection during thoracoabdominal aneurysm repair. a five-year experience. J Vasc Surg 2000;31:1093-1102.[Medline]
  3. Safi HJ, Miller III CC, Carr C, Iliopoulos DC, Dorsay DA, Baldwin JC. Importance of intercostal artery reattachment during thoracoabdominal aortic aneurysm repair. J Vasc Surg 1998;27:58-68.[Medline]
  4. Cambria RP, Clouse WD, Davison JK, Dunn PF, Corey M, Dorer D. Thoracoabdominal aneurysm repair. results with 337 operations performed over a 15-year interval. Ann Surg 2002;236:471-479.[Medline]
  5. Kouchoukos NT, Dougenis D. Surgery of thoracic aorta. N Engl J Med 1997;26:1876-1888.
  6. Gravereaux E, Faries PL, Burks JA, Latessa V, Spielvogel D, Hollier LH, et al. Risk of spinal cord ischemia after endograft repair of thoracic aortic aneurysms. J Vasc Surg 2001;34:997-1003.[Medline]
  7. Svensson LG. Natural history on aneurysms of the descending and thoracoabdominal aorta. J Card Surg 1997;12(suppl):279-284.[Medline]
  8. Bortone AS, Schena S, D'Agostino D, Dialetto G, Paradiso V, Mannatrizio G, et al. Immediate versus delayed endovascular treatment of post-traumatic aortic pseudo-aneurysms and type B dissections. retrospective analysis and premises to the upcoming European trial. Circulation 2002;106(suppl 1):234-240.
  9. Volodos NL, Karpovich IP, Troyan VI, Kalashnikova YV, Shekhanin VE, Ternyuk NE, et al. Clinical experience of the use of self-fixing synthetic prostheses for remote endoprosthetics of the thoracic and the abdominal aorta and iliac arteries through the femoral artery and as intraoperative endoprosthesis for aorta reconstruction. Vasa Suppl 1991;33:93-95.[Medline]
  10. Dake MD, Miller DC, Semba CP, Mitchell RS, Walker PJ, Liddell RP. Transluminal placement of endovascular stent grafts for the treatment of descending thoracic aortic aneurysms. N Engl J Med 1994;331:1729-1734.[Medline]
  11. Agence Française de Sécurité Sanitaire des Aliments et des Produits de Santé. Evaluation des endoprothèses aortiques utilisées pour le traitement endovasculaire des anévrismes de l'aorte abdominale sous-rénale. Paris: Agence Française de Sécurité Sanitaire des Aliments et des Produits de Santé, 2001. English summary available at: http://agmed.sante.gouv.fr/html/10/endropo/engando.pdf..
  12. Ricco JB, Goeau-Brissonniere O, Rodde-Dunet MH, Marty M, Fender P, Allemand H, et al. Use of abdominal aortic endovascular prostheses in France from 1999 to 2001. J Vasc Surg 2003;38:1273-1282.[Medline]
  13. Dake MD, Miller DC, Mitchell RS, Semba CP, Moore KA, Sakai T. The "first generation" of endovascular stent grafts for patients with aneurysms of the descending thoracic aorta. J Thorac Cardiovasc Surg 1998;116:689-704.[Abstract/Free Full Text]
  14. Demers P, Miller DC, Mitchell RS, Kee ST, Sze D, Razavi MK, et al. Midterm results of endovascular repair of descending thoracic aortic aneurysms with first-generation stent grafts. J Thorac Cardiovasc Surg 2004;127:664-673.[Abstract/Free Full Text]
  15. Neuhauser B, Perkmann R, Greiner A, Steingruber I, Tauscher T, Jaschke W, et al. Mid-term results after endovascular repair of the atherosclerotic descending thoracic aortic aneurysm. Eur J Vasc Endovasc Surg 2004;28:146-153.[Medline]
  16. Mitchell RS, Miller DC, Dake MD, Semba CP, Moore KA, Sakai T. Thoracic aortic aneurysm repair with an endovascular stent graft. the "first generation". Ann Thorac Surg 1999;67:1971-1974.[Abstract/Free Full Text]
  17. Greenberg R, Resch T, Nyman U, Lindh M, Brunkwall J, Brunkwall P, et al. Endovascular repair of descending thoracic aortic aneurysms. an early experience with intermediate-term follow-up. J Vasc Surg 2000;31:147-156.[Medline]
  18. Melissano G, Tshomba Y, Civilini E, Chiesa R. Disappointing results with a new commercially available thoracic endograft. J Vasc Surg 2004;39:124-130.[Medline]
  19. Jacobs TS, Won J, Gravereaux EC, Faries PL, Morrissey N, Teodorescu VJ, et al. Mechanical failure of prosthetic human implants. a 10-year experience with aortic stent graft devices. J Vasc Surg 2003;37:16-26.[Medline]
  20. Roseborough G, Burke J, Sperry J, Perler B, Parra J, Williams GM. Twenty-year experience with acute distal thoracic aortic dissections. J Vasc Surg 2004;40:235-246.[Medline]
  21. Borst HG, Heinemann MK, Stone CD. Surgical treatment of aortic dissection. New York: Churchill Livingstone; 1996.
  22. Dake MD, Kato N, Mitchell RS, Semba CP, Razavi MK, Shimono T, et al. Endovascular stent graft placement for the treatment of acute aortic dissection. N Engl J Med 1999;340:1546-1552.[Medline]
  23. Greenberg R, Khwaja J, Haulon S, Fulton G. Aortic dissections. new perspectives and treatment paradigms. Eur J Vasc Endovasc Surg 2003;26:579-586.[Medline]
  24. Demers P, Miller C, Scott Mitchell R, Kee ST, Lynn Chagonjian RN, Dake MD. Chronic traumatic aneurysms of the descending thoracic aorta. mid-term results of endovascular repair using first and second-generation stent grafts. Eur J Cardiothorac Surg 2004;25:394-400.[Abstract/Free Full Text]
  25. Semba CP, Sakai T, Slonim SM, Razavi MK, Kee ST, Jorgensen MJ, et al. Mycotic aneurysms of the thoracic aorta. repair with use of endovascular stent-grafts. J Vasc Interv Radiol 1998;9:33-40.[Medline]

Related Article

Thoracic aortic stent grafting: Is it ready for prime time?
Thomas G. Gleason
J. Thorac. Cardiovasc. Surg. 2006 131: 16-18. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Eur J Cardiothorac SurgHome page
P. Narayan, A. Wong, I. Davies, G. D. Angelini, A. J. Bryan, P. Wilde, and G. J. Murphy
Thoracic endovascular repair versus open surgical repair -- which is the more cost-effective intervention for descending thoracic aortic pathologies?
Eur J Cardiothorac Surg, October 1, 2011; 40(4): 869 - 874.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
T. Kuratani, M. Kato, Y. Shirakawa, K. Shimamura, and Y. Sawa
Long-term results of hybrid endovascular repair for thoraco-abdominal aortic aneurysms
Eur J Cardiothorac Surg, September 1, 2010; 38(3): 299 - 304.
[Abstract] [Full Text] [PDF]

Home page
 VascularHome page
S. T. Mustafa, U. Sadat, M. U. Majeed, C. M. Wong, J. Michaels, and S. M. Thomas
Endovascular Repair of Nonruptured Thoracic Aortic Aneurysms: Systematic Review
Vascular, February 1, 2010; 18(1): 28 - 33.
[Abstract] [Full Text] [PDF]

Home page
 Interact CardioVasc Thorac SurgHome page
R. M. S. Almeida, J. C. Leal, E. K. Saadi, D. M. Braile, A. S. T. Rocha, G. Volpiani, C. Centola, and A. Zago
Thoracic endovascular aortic repair - a Brazilian experience in 255 patients over a period of 112 months
Interact CardioVasc Thorac Surg, May 1, 2009; 8(5): 524 - 528.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
A. Stewart
Why are we still talking about open repair of descending aneurysms?
J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 278 - 279.
[Full Text] [PDF]

Home page
 Card Surg AdultHome page
S. D. Moffatt-Bruce and R. S. Mitchell
Endovascular Therapy for the Treatment of Thoracic Aortic Disease
Card. Surg. Adult, January 1, 2008; 3(2008): 1299 - 1308.
[Full Text]

Home page
 Ann. Thorac. Surg.Home page
L. G. Svensson, N. T. Kouchoukos, D. C. Miller, J. E. Bavaria, J. S. Coselli, M. A. Curi, H. Eggebrecht, J. A. Elefteriades, R. Erbel, T. G. Gleason, et al.
Expert Consensus Document on the Treatment of Descending Thoracic Aortic Disease Using Endovascular Stent-Grafts
Ann. Thorac. Surg., January 1, 2008; 85(1_Supplement): S1 - S41.
[Abstract] [Full Text] [PDF]

Home page
 PERSPECT VASC SURG ENDOVASC THERHome page
T. G. Gleason and L. C. Benjamin
Conventional Open Repair of Descending Thoracic Aortic Aneurysms
Perspectives in Vascular Surgery and Endovascular Therapy, June 1, 2007; 19(2): 110 - 121.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. Czerny, M. Grimm, D. Zimpfer, S. Rodler, R. Gottardi, D. Hutschala, J. Lammer, E. Wolner, and M. Schoder
Results After Endovascular Stent Graft Placement in Atherosclerotic Aneurysms Involving the Descending Aorta
Ann. Thorac. Surg., February 1, 2007; 83(2): 450 - 455.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
T. G. Gleason
Thoracic aortic stent grafting: Is it ready for prime time?
J. Thorac. Cardiovasc. Surg., January 1, 2006; 131(1): 16 - 18.
[Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ricco, J.-B.
Right arrow Articles by Corsini, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ricco, J.-B.
Right arrow Articles by Corsini, A.
Related Collections
Right arrow Great vessels
Right arrowRelated Article

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS